Skip to main content

Table 1 Results of bronchiolar lavage fluid analysis (104/ml) in the four groups

From: Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery

 

Control

C + LPS

C + LPS + I

C + LPS + N

Total cells

6.00 ± 2.35

80.60 ± 16.30**

36.20 ± 7.26##

43.40 ± 6.91##

Macrophages

3.67 ± 2.15

4.18 ± 0.68

5.63 ± 3.20

3.49 ± 4.88

Lymphocytes

0.00 ± 0.00

0.34 ± 0.56

0.00 ± 0.00

0.00 ± 0.00

Neutrophils

0.00 ± 0.00

71.46 ± 16.09**

26.38 ± 2.85##

14.46 ± 20.24##

Eosinophils

0.34 ± 0.21

4.64 ± 3.95

4.20 ± 4.81

2.04 ± 2.83

  1. Results are presented as mean ± SD. LPS, lipopolysaccharide; C, cyclophosphamide; I, imatinib; N, nilotinib. **P <0.01 for control versus C + LPS; ##P <0.01 for C + LPS versus C + LPS + I or N.
Back to article page

Critical Care

ISSN: 1364-8535